Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

xchrom

(108,903 posts)
Wed Aug 15, 2012, 03:06 PM Aug 2012

Commercial ebola vaccine 'unlikely' say researchers

http://www.bbc.co.uk/news/science-environment-19112510


Ebola is one of the most feared viruses known to science

***SNIP


As a result of this funding, several vaccine candidates have been developed and have shown themselves effective in animal trials.

Two companies, Sarepta and Tekmira have begun human safety trials of their vaccines.

But in recent days, both companies have been told by the Defense Department to temporarily stop work on their vaccines due to funding constraints. It is expected that a decision to either resume testing or completely terminate the contracts will be made by early September.

Scientists say their understanding of the nature of the virus has markedly improved over the past decade. But the chances of turning that knowledge into a vaccine are very dependent on money.
2 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Commercial ebola vaccine 'unlikely' say researchers (Original Post) xchrom Aug 2012 OP
Has the source of the outbreaks ever been identified? hedgehog Aug 2012 #1
why is the defense department doing this? mopinko Aug 2012 #2

mopinko

(70,178 posts)
2. why is the defense department doing this?
Thu Aug 16, 2012, 10:35 AM
Aug 2012

ok, i know why, but still. not surprised that this is the sort of thing they would be looking to cut. who cares if gi's get ebola, or bring it back home, as long as we have overpriced fast planes and things that go boom.

Latest Discussions»Issue Forums»Health»Commercial ebola vaccine ...